Non-Randomized, Multi-Site, Single-Arm Study of the LinguaFlex™ Tongue Retractor (LTR) for the Treatment of Moderate to Severe Obstructive Sleep Apnea and Snoring in Adult Subjects

Status: Enrolling_by_invitation
Location: See all (3) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The LinguaFlex™ Tongue Retractor (LTR) is an investigational medical device that is inserted into the tongue to lessen its backward movement during sleep. This helps to keep the airway open during sleep so that the tongue doesn't block the airway causing obstructive apnea or narrow it enough to cause snoring. This study will monitor the effectiveness of the LTR device in the reduction of Obstructive Sleep Apnea and snoring over the course of a one-year treatment period.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Subjects able to read, understand and sign consent

• Subjects 18 years or older with:

‣ Moderate to severe OSA (AHI of ≥ 15 to ≤ 50 as determined by a Diagnostic PSG recording within 2 months of inclusion)

⁃ Subject agrees not to use any type of additional OSA therapy including PAP therapy throughout the course of the study

Locations
United States
Massachusetts
St. Elizabeth's Medical Center
Brighton
Wisconsin
Medical College of Wisconsin
Milwaukee
West Virginia
WVU Medicine / J. W. Ruby Memorial Hospital
Morgantown
Time Frame
Start Date: 2020-01-10
Completion Date: 2026-04
Participants
Target number of participants: 80
Treatments
Experimental: LTR Treatment
Eligible subjects will undergo insertion of the LTR device in their tongue. Initiation of treatment will occur 7 days post insertion procedure and will be monitored over the course of 1 year.
Related Therapeutic Areas
Sponsors
Leads: Linguaflex, Inc.

This content was sourced from clinicaltrials.gov